메뉴 건너뛰기




Volumn 17, Issue 5, 2009, Pages 541-542

Apo E and hyperlipidemia type III: Unraveling hyperlipidemia type III (dysbetalipoproteinemia), slowly

(1)  Schaefer, Juergen R a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHYLOMICRON; VERY LOW DENSITY LIPOPROTEIN; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; APOLIPOPROTEIN C3; HEPATIC LIPASE, HUMAN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL LIPASE;

EID: 67349106797     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.222     Document Type: Note
Times cited : (16)

References (6)
  • 1
    • 67349172252 scopus 로고    scopus 로고
    • Henneman P, van der Sman-de Beer F, Hanifi Moghaddam P et al: The expression of type III hyperlipoproteinemia: Involvement of lipolysis genes. Eur J Hum Genet 2009; 17: 620-628 (this issue).
    • Henneman P, van der Sman-de Beer F, Hanifi Moghaddam P et al: The expression of type III hyperlipoproteinemia: Involvement of lipolysis genes. Eur J Hum Genet 2009; 17: 620-628 (this issue).
  • 2
    • 0016635833 scopus 로고
    • The biochemical, clinical, and genetic features of type III hyperlipoproteinemia
    • Morganroth J, Levy RI, Fredrickson DS: The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann Intern Med 1975; 82: 158-174.
    • (1975) Ann Intern Med , vol.82 , pp. 158-174
    • Morganroth, J.1    Levy, R.I.2    Fredrickson, D.S.3
  • 3
    • 0017773790 scopus 로고
    • Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
    • Utermann G, Hees M, Steinmetz A: Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 1977; 269 604-607.
    • (1977) Nature , vol.269 , pp. 604-607
    • Utermann, G.1    Hees, M.2    Steinmetz, A.3
  • 4
    • 7044235073 scopus 로고    scopus 로고
    • Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: Apolipoprotein A5 S19W mutation as a cofactor
    • Schaefer JR, Sattler AM, Hackler B et al: Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: Apolipoprotein A5 S19W mutation as a cofactor. Clin Chem 2004; 50: 2214.
    • (2004) Clin Chem , vol.50 , pp. 2214
    • Schaefer, J.R.1    Sattler, A.M.2    Hackler, B.3
  • 5
    • 25144449725 scopus 로고    scopus 로고
    • Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia
    • Evans D, Seedorf U, Beil FU: Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia. Clin Genet 2005; 68 369-372.
    • (2005) Clin Genet , vol.68 , pp. 369-372
    • Evans, D.1    Seedorf, U.2    Beil, F.U.3
  • 6
    • 35348888266 scopus 로고    scopus 로고
    • The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III Hyperlipidemia
    • Evans D, Beil F: The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III Hyperlipidemia. BMC Med Genet 2007; 8: 56.
    • (2007) BMC Med Genet , vol.8 , pp. 56
    • Evans, D.1    Beil, F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.